Bio-Rad Laboratoriesvs.IDEXX Laboratories
BIO vs IDXX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
IDEXX Laboratories is about 5.6× larger than Bio-Rad Laboratories by market cap; IDEXX Laboratories trades at the lower P/E (40.7 vs 47.1); year to date, Bio-Rad Laboratories leads (−2.3% vs −16.7%).
Side by side
| BIO | IDXX | |
|---|---|---|
| Market cap | $8B | $44.5B |
| Price | $296.11 | $563.57 |
| Today | −0.4% | +0.9% |
| Return YTD | −2.3% | −16.7% |
| Return 1Y | +13.9% | +4.2% |
| P/E | 47.1 | 40.7 |
| P/S | 3.1 | 10.0 |
| P/B | 1.2 | 28.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Bio-Rad LaboratoriesBIO
American manufacturer of products for clinical diagnostics and life science research — including blood typing and droplet digital PCR.
Full BIO profile →IDEXX LaboratoriesIDXX
Diagnostics and software for veterinarians; market leader in veterinary diagnostics.
Full IDXX profile →More comparisons in Diagnostics
See where BIO and IDXX sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →